Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 09-2000 | 09-1999 | |
| Sales | 2,440 | 137 | N/A | N/A | N/A |
| Cost of Goods | 1,780 | N/A | N/A | N/A | N/A |
| Gross Profit | 659 | 137 | N/A | N/A | N/A |
| Operating Expenses | 28,842 | 19,612 | 5,085 | 273 | 192 |
| Operating Income | -28,182 | -19,475 | -5,085 | -273 | -192 |
| Interest Expense | 1,686 | 20 | 7 | N/A | N/A |
| Other Income | 8,080 | 8,426 | 118 | 3 | 3 |
| Pre-tax Income | -21,788 | -11,069 | -4,974 | -270 | -189 |
| Income Tax | -2,279 | -1,327 | 0 | N/A | N/A |
| Net Income Continuous | -19,509 | -9,742 | -4,974 | -270 | -189 |
| Net Income | $-19,509 | $-9,742 | $-4,974 | $-270 | $-189 |
| EPS Basic Total Ops | -0.08 | -0.05 | -0.04 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | -0.04 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.08 | -0.05 | -0.04 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | -0.04 | -0.01 | 0.00 |
| EBITDA(a) | $-17,137 | $-11,048 | $-4,967 | $-273 | $-192 |